المؤلفون: Claire Gkatzoudi, Izolde Bouloukaki, Charalampos Mamoulakis, Christos Lionis, Ioanna Tsiligianni

المصدر: Medicina, Vol 60, Iss 3, p 389 (2024)

مصطلحات موضوعية: LUTS, ED, UI, primary care, screening, quality of life, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/3/389; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

URL الوصول: https://doaj.org/article/13b295e076494a9cb4c97b15602cfca0

المؤلفون: Good Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA., Spiegel JY; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Malipatlolla MB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Ehlinger ZJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Kurra S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Homer Stryker M.D. School of Medicine, Western Michigan University, Kalamazoo, MI, USA., Desai MH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Reynolds WD; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wong Lin A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Research Lab, Flow Cytometry Core Facility, University of California, Berkeley, Berkeley, CA, USA., Vandris P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wu F; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Prabhu S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Hamilton MP; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Tamaresis JS; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Hanson PJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Syncopation Life Sciences, San Mateo, CA, USA., Feldman SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Baird JH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Department of Hematology and Hematopoietic Cell Transplantation, Division of Lymphoma, City of Hope National Medical Center, Duarte, CA, USA., Muffly L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Claire GK; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Craig J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Kong KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wagh D; Stanford Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA., Coller J; Stanford Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA., Bendall SC; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Tibshirani RJ; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Department of Statistics, Stanford University, Stanford, CA, USA., Plevritis SK; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA., Miklos DB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.

المصدر: Nature medicine [Nat Med] 2022 Sep; Vol. 28 (9), pp. 1860-1871. Date of Electronic Publication: 2022 Sep 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Neurotoxicity Syndromes*/etiology , Receptors, Chimeric Antigen*, Antigens, CD19 ; Humans ; Immunotherapy, Adoptive/adverse effects ; Immunotherapy, Adoptive/methods ; Lactate Dehydrogenases ; Proteomics ; Receptors, Antigen, T-Cell

المؤلفون: Frank MJ; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA., Hossain NM; Loyola University Chicago, Stritch School of Medicine, Maywood, IL., Bukhari A; University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center, Baltimore, MD., Dean E; Moffitt Cancer Center, Tampa, FL., Spiegel JY; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA., Claire GK; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA., Kirsch I; Adaptive Biotechnologies, Seattle, WA., Jacob AP; Adaptive Biotechnologies, Seattle, WA., Mullins CD; Adaptive Biotechnologies, Seattle, WA., Lee LW; Adaptive Biotechnologies, Seattle, WA., Kong KA; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA., Craig J; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA., Mackall CL; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA.; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA., Rapoport AP; University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center, Baltimore, MD., Jain MD; Moffitt Cancer Center, Tampa, FL., Dahiya S; University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center, Baltimore, MD., Locke FL; Moffitt Cancer Center, Tampa, FL., Miklos DB; Division of Blood and Stem Cell Transplantation, Department of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Sep 20; Vol. 39 (27), pp. 3034-3043. Date of Electronic Publication: 2021 Jun 16.

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*therapeutic use , Circulating Tumor DNA/*genetics , Lymphoma, Large B-Cell, Diffuse/*drug therapy, Adult ; Aged ; Biological Products/pharmacology ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prospective Studies ; Young Adult

المؤلفون: Baird JH; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Epstein DJ; Division of Infectious Diseases and Geographic Medicine, Department of Medicine., Tamaresis JS; Department of Biomedical Data Science, and., Ehlinger Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Spiegel JY; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Craig J; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Claire GK; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Frank MJ; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Muffly L; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Shiraz P; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Meyer E; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Arai S; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Brown JW; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Division of Infectious Diseases and Geographic Medicine, Department of Medicine., Johnston L; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Lowsky R; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Negrin RS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Rezvani AR; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Weng WK; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Latchford T; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Mackall CL; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and.; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Miklos DB; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and., Sidana S; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA; and.

المصدر: Blood advances [Blood Adv] 2021 Jan 12; Vol. 5 (1), pp. 143-155.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Immune Reconstitution* , Lymphoma, Large B-Cell, Diffuse*, Antigens, CD19/therapeutic use ; Biological Products ; Humans ; Immunotherapy, Adoptive